Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
Resource Type
Article
Authors
Redfield, Robert R. ; Jordan, Stanley C. ; Busque, Stephan ; Vincenti, Flavio ; Woodle, E. Steve ; Desai, Niraj ; Reed, Elaine F. ; Tremblay, Simon ; Zachary, Andrea A. ; Vo, Ashley A. ; Formica, Richard ; Schindler, Thomas ; Tran, Ha ; Looney, Caroline ; Jamois, Candice ; Green, Cherie ; Morimoto, Alyssa ; Rajwanshi, Richa ; Schroeder, Aaron ; Cascino, Matthew D. ; Brunetta, Paul ; Borie, Dominic
Source
In American Journal of Transplantation November 2019 19(11):3035-3045
Subject
Language
ISSN
1600-6135